Id |
Subject |
Object |
Predicate |
Lexical cue |
T367 |
0-126 |
Sentence |
denotes |
Table 2 The KEGG (A) and GO (B) enrichment analysis results for miR-8066, 5197-3p, 3611, 3934-3p, 1468-5p, 3691, and 1307-3p. |
T368 |
127-172 |
Sentence |
denotes |
KEGG Pathway (A) p-Value #genes #miRNAs |
T369 |
173-224 |
Sentence |
denotes |
Mucin type O-Glycan biosynthesis 2.52 × 10−2 7 3 |
T370 |
225-271 |
Sentence |
denotes |
TGF-beta signaling pathway 4.96 × 10−1 12 4 |
T371 |
272-311 |
Sentence |
denotes |
Morphine addiction 0.0001128919 14 5 |
T372 |
312-376 |
Sentence |
denotes |
Metabolism of xenobiotics by cytochrome P450 0.0002215491 5 2 |
T373 |
377-433 |
Sentence |
denotes |
Other types of O-glycan biosynthesis 0.0003646344 1 1 |
T374 |
434-485 |
Sentence |
denotes |
Vitamin digestion and absorption 0.001008222 2 1 |
T375 |
486-558 |
Sentence |
denotes |
Glycosaminoglycan biosynthesis—heparan sulfate/heparin 0.00385809 1 1 |
T376 |
559-595 |
Sentence |
denotes |
GABAergic synapse 0.01342039 13 4 |
T377 |
596-652 |
Sentence |
denotes |
Cytokine-cytokine receptor interaction 0.02096334 9 1 |
T378 |
653-725 |
Sentence |
denotes |
Signaling pathways regulating pluripotency of stem cells 0.180299 9 1 |
T379 |
726-764 |
Sentence |
denotes |
Amphetamine addiction 0.2150865 7 1 |
T380 |
765-796 |
Sentence |
denotes |
Axon guidance 0.2239648 22 3 |
T381 |
797-837 |
Sentence |
denotes |
Hippo signaling pathway 0.2278356 7 1 |
T382 |
838-882 |
Sentence |
denotes |
Prolactin signaling pathway 0.2284669 5 1 |
T383 |
883-925 |
Sentence |
denotes |
mRNA surveillance pathway 0.2795597 1 1 |
T384 |
926-999 |
Sentence |
denotes |
Glycosphingolipid biosynthesis—lacto and neolacto series 0.3157068 1 1 |
T385 |
1000-1031 |
Sentence |
denotes |
Bile secretion 0.4120997 1 1 |
T386 |
1032-1070 |
Sentence |
denotes |
Circadian entrainment 0.4608082 9 1 |
T387 |
1071-1108 |
Sentence |
denotes |
N-Glycan biosynthesis 0.488078 2 1 |
T388 |
1109-1141 |
Sentence |
denotes |
Mismatch repair 0.6174557 1 1 |
T389 |
1142-1190 |
Sentence |
denotes |
Drug metabolism—cytochrome P450 0.7063987 6 1 |
T390 |
1191-1229 |
Sentence |
denotes |
Glutamatergic synapse 0.7319762 6 1 |
T391 |
1230-1276 |
Sentence |
denotes |
Glycosaminoglycan degradation 0.7395672 2 1 |
T392 |
1277-1329 |
Sentence |
denotes |
Antigen processing and presentation 0.7591685 1 1 |
T393 |
1330-1374 |
Sentence |
denotes |
GO Category (B) p-Value #genes #miRNAs |
T394 |
1375-1403 |
Sentence |
denotes |
organelle 1 × 10−38 848 6 |
T395 |
1404-1467 |
Sentence |
denotes |
cellular nitrogen compound metabolic process 1 × 10−12 414 7 |
T396 |
1468-1497 |
Sentence |
denotes |
ion binding 8 × 10−8 495 7 |
T397 |
1498-1536 |
Sentence |
denotes |
biosynthetic process 3 × 10−7 351 7 |
T398 |
1537-1605 |
Sentence |
denotes |
nucleic acid binding transcription factor activity 4 × 10−2 115 6 |
T399 |
1606-1660 |
Sentence |
denotes |
cellular protein modification process 2 × 101 205 7 |
T400 |
1661-1697 |
Sentence |
denotes |
molecular_function 5 × 103 1303 7 |
T401 |
1698-1734 |
Sentence |
denotes |
cellular_component 1 × 105 1312 7 |
T402 |
1735-1766 |
Sentence |
denotes |
enzyme binding 2 × 105 119 5 |
T403 |
1767-1798 |
Sentence |
denotes |
gene expression 3 × 105 54 6 |
T404 |
1799-1860 |
Sentence |
denotes |
protein binding transcription factor activity 1 × 106 52 5 |
T405 |
1861-1904 |
Sentence |
denotes |
blood coagulation 0.000176061599974 44 6 |
T406 |
1905-1946 |
Sentence |
denotes |
protein complex 0.00115693944276 290 5 |
T407 |
1947-2011 |
Sentence |
denotes |
post-translational protein modification 0.00185490003064 19 5 |
T408 |
2012-2080 |
Sentence |
denotes |
neurotrophin TRK receptor signaling pathway 0.00197464302174 24 5 |
T409 |
2081-2127 |
Sentence |
denotes |
synaptic transmission 0.00204631087649 42 5 |
T410 |
2128-2187 |
Sentence |
denotes |
cellular protein metabolic process 0.00275618650845 39 5 |
T411 |
2188-2246 |
Sentence |
denotes |
small molecule metabolic process 0.00275618650845 170 7 |
T412 |
2247-2300 |
Sentence |
denotes |
cytoskeletal protein binding 0.00396272124679 68 4 |
T413 |
2301-2345 |
Sentence |
denotes |
cell-cell signaling 0.00396272124679 60 5 |
T414 |
2346-2400 |
Sentence |
denotes |
transcription, DNA-templated 0.00450420995446 208 6 |
T415 |
2401-2477 |
Sentence |
denotes |
symbiosis, encompassing mutualism through parasitism 0.0140041886634 41 5 |
T416 |
2478-2520 |
Sentence |
denotes |
catabolic process 0.0141620388146 142 6 |
T417 |
2521-2582 |
Sentence |
denotes |
Fc-epsilon receptor signaling pathway 0.0222360628043 15 6 |
T418 |
2583-2632 |
Sentence |
denotes |
cellular component assembly 0.02375306792 99 5 |
T419 |
2633-2713 |
Sentence |
denotes |
transcription initiation from RNA polymerase II promoter 0.0250016205995 24 5 |
T420 |
2714-2749 |
Sentence |
denotes |
nucleoplasm 0.0335128910566 92 6 |
T421 |
2750-2793 |
Sentence |
denotes |
platelet activation 0.0350801245107 20 5 |
T422 |
2794-2875 |
Sentence |
denotes |
positive regulation of telomere maintenance via telomerase 0.0370638891992 3 3 |
T423 |
2876-3056 |
Sentence |
denotes |
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription 0.0448871926331 32 5 |
T424 |
3057-3099 |
Sentence |
denotes |
O-glycan processing 0.0449415771561 8 5 |